GRM5: A G Protein-Coupled Receptor for Pain Modulation and Other Signaling Functions

Target Name: GRM5

NCBI ID: G2915

GRM5

GRM5: A G Protein-Coupled Receptor for Pain Modulation and Other Signaling Functions

G protein-coupled receptors (GRMs) are a family of transmembrane proteins that play a crucial role in cellular signaling. They are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. Out of the many GRMs, the G protein-coupled receptor GRM5 (PP1R86) has garnered significant attention due to its unique function and potential as a drug target or biomarker.

GRM5: Structure and Function

GRM5 is a 7-transmembrane protein that belongs to the GRM family. It is characterized by a long extracellular domain, a transmembrane segment, and an intracellular tail. The GRM5 receptor is expressed in various tissues, including the brain, eye, heart, and pancreas, and is involved in various signaling pathways.

GRM5 receptor function is dependent on its catalytic activity, which is mediated by its transmembrane domain. The transmembrane domain of GRM5 consists of a nucleotide-binding oligomerization (NBO) domain and a transmembrane segment. The NBO domain is responsible for the receptor's catalytic activity, while the transmembrane segment modulates the receptor's trafficking and localization.

GRM5 is a G protein-coupled receptor that is involved in various signaling pathways. One of the well-established functions of GRM5 is its role in pain modulation. It is known to play a crucial role in the regulation of pain perception and neuroinflammation.

GRM5 has also been shown to be involved in the regulation of anxiety and depression. Studies have shown that GRM5 is positively correlated with anxiety and depression symptoms, and that its levels are decreased in individuals with these conditions.

GRM5 has also been shown to play a role in the regulation of inflammation. Studies have shown that GRM5 is involved in the regulation of inflammatory cytokine production and that its levels are decreased in individuals with inflammatory diseases.

GRM5 as a Drug Target

GRM5's unique function and its potential as a drug target have led to a significant amount of research on its potential therapeutic applications. One of the main targets of GRM5 is its role in pain modulation.

Theorized therapeutic applications for GRM5 include the development of pain modulators, such as opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioid- combination therapies. Additionally, GRM5 has also been targeted with drugs that block its signaling, such as small molecules, peptides, and antibodies.

GRM5 has also been suggested as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Conclusion

GRM5 is a G protein-coupled receptor that is involved in various signaling pathways and has been shown to play a crucial role in pain modulation, anxiety, and depression. Its unique function and potential as a drug target and biomarker have led to a significant amount of research on its potential therapeutic applications. Further research is needed to fully understand the role of GRM5 in disease and to develop safe and effective drugs that target this protein.

Protein Name: Glutamate Metabotropic Receptor 5

Functions: G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol-calcium second messenger system and generates a calcium-activated chloride current. Plays an important role in the regulation of synaptic plasticity and the modulation of the neural network activity

The "GRM5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GRM5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets